Update on Smoking Cessation: E-Cigarettes, Emerging Tobacco Products Trends, and New Technology-Based Interventions
Department of Psychiatry; Systems and Psychosocial Advances Research Center
Psychiatry | Psychiatry and Psychology | Substance Abuse and Addiction
Tobacco use disorders (TUDs) continue to be overly represented in patients treated in mental health and addiction treatment settings. It is the most common substance use disorder (SUD) and the leading cause of health disparities and increased morbidity/mortality amongst individuals with a psychiatric disorder. There are seven Food and Drug Administration (FDA) approved medications and excellent evidence-based psychosocial treatment interventions to use in TUD treatment. In the past few years, access to and use of other tobacco or nicotine emerging products are on the rise, including the highly publicized electronic cigarette (e-cigarette). There has also been a proliferation of technology-based interventions to support standard TUD treatment, including mobile apps and web-based interventions. These tools are easily accessed 24/7 to support outpatient treatment. This update will review the emerging products and counter-measure intervention technologies, including how clinicians can integrate these tools and other community-based resources into their practice.
Rights and Permissions
Citation: Curr Psychiatry Rep. 2016 May;18(5):51. doi: 10.1007/s11920-016-0681-6. Link to article on publisher's site
Addiction, E-Cigarettes, Mobile health, Nicotine, Smoking cessation, Tobacco, Tobacco use disorder
Current psychiatry reports
Das, Smita; Tonelli, Makenzie E.; and Ziedonis, Douglas M., "Update on Smoking Cessation: E-Cigarettes, Emerging Tobacco Products Trends, and New Technology-Based Interventions" (2016). University of Massachusetts Medical School Faculty Publications. 1117.